Percutaneous coronary intervention for ST-elevation myocardial infarction complicated by cardiogenic shock in a

Kensaku Nishihira1, Satoshi Honda2, Misa Takegami3,4

  • 1Department of Cardiology, Miyazaki Medical Association Hospital, 1173 Arita, Miyazaki 880-2102, Japan.

Insights

Percutaneous coronary intervention (PCI) significantly reduces in-hospital mortality for ST-segment elevation myocardial infarction with cardiogenic shock (STEMICS). This benefit was observed even in elderly patients, suggesting age alone should not prevent this life-saving treatment.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Myocardial Infarction Research

Background:

  • ST-segment elevation myocardial infarction complicated by cardiogenic shock (STEMICS) carries a high mortality rate.
  • Increasing life expectancy leads to more elderly patients with acute myocardial infarction (AMI) undergoing interventions.
  • Percutaneous coronary intervention (PCI) is increasingly used in acute myocardial infarction (AMI) patients, including the elderly.

Purpose of the Study:

  • To investigate the characteristics of patients with STEMICS.
  • To evaluate the impact of PCI on in-hospital mortality in STEMICS patients.
  • To assess PCI's effectiveness in elderly STEMICS patients.

Main Methods:

  • Retrospective analysis of the Japan AMI Registry (JAMIR) database (2011-2016).
  • Comparison of 2760 STEMICS patients: 2396 who underwent PCI versus 364 who did not.
  • Subgroup analysis of 789 patients aged ≥80 years.

Main Results:

  • In-hospital mortality for STEMICS was 34.6%, with 69.3% receiving mechanical circulatory support.
  • PCI was associated with significantly lower in-hospital mortality (31.3% vs. 56.0%, P < 0.001).
  • PCI independently reduced in-hospital mortality (adjusted OR, 0.508) and cardiac deaths in elderly patients (adjusted OR, 0.524).

Conclusions:

  • PCI is effective in reducing in-hospital cardiac death in elderly patients with STEMICS in Japan.
  • Age should not be a barrier to considering PCI in STEMICS patients.
  • PCI offers a potentially beneficial invasive therapy for STEMICS, regardless of age.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
11
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
17
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
16
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
9